Summary & Overview
CPT 70544: MRI Orbit, Face, and Neck Without and With Contrast
CPT code 70544 represents magnetic resonance imaging (MRI) of the orbit, face, and neck, performed initially without contrast and then with contrast material for additional imaging sequences. This radiology procedure is a critical diagnostic tool for evaluating complex anatomical regions and is widely used in clinical practice across the United States. The code is relevant for outpatient hospital and diagnostic imaging center settings, reflecting its accessibility and importance in routine and specialized care.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, provide coverage for this service, underscoring its clinical and policy significance. Readers will gain insights into payer coverage, clinical indications, and related coding benchmarks. The publication also addresses associated modifiers, taxonomies, and ICD-10 diagnoses, offering a comprehensive overview of billing and policy considerations for this MRI procedure. Additionally, comparisons to related CPT codes and updates on reimbursement trends are included, equipping stakeholders with the latest information for informed decision-making in radiology billing and compliance.
CPT Code Overview
CPT code 70544 is used to report magnetic resonance imaging (MRI) of the orbit, face, and neck performed without contrast material, followed by the administration of contrast material and further imaging sequences. This procedure is classified under radiology and is typically conducted in an outpatient hospital or diagnostic imaging center setting. MRI scans of this region are essential for detailed evaluation of anatomical structures and are frequently utilized in the diagnosis and management of various conditions affecting the orbit, face, and neck.
Clinical & Coding Specifications
Clinical Context
A patient presents to an outpatient hospital or diagnostic imaging center with symptoms such as unexplained swelling, pain, or masses in the orbit, face, or neck. The referring provider suspects a possible malignancy, infection, or neurological disorder affecting these regions. To further evaluate the anatomy and pathology, the provider orders a magnetic resonance imaging (MRI) of the orbit, face, and neck. The procedure involves initial imaging without contrast, followed by administration of contrast material and additional sequences to enhance visualization of abnormal tissues. The radiologist interprets the images to assist in diagnosis and treatment planning.
Coding Specifications
-
Modifier
26: Used to indicate the professional component, which covers the radiologist's interpretation and report of the MRI. -
Modifier
TC: Used to indicate the technical component, which covers the use of equipment, supplies, and technical staff for performing the MRI.
| Modifier Code | Description |
|---|---|
26 | Professional component |
TC | Technical component |
-
Provider Taxonomies:
2085R0202X- Radiology, Diagnostic Radiology2085N0700X- Radiology, Neuroradiology2085P0229X- Radiology, Pediatric Radiology
These taxonomies represent specialties qualified to perform and interpret MRI procedures of the orbit, face, and neck.
Related Diagnoses
-
A52.05- Other cerebrovascular syphilis- Relevant for evaluating neurosyphilis affecting cerebrovascular structures in the orbit, face, or neck.
-
A52.19- Other symptomatic neurosyphilis- Used when neurosyphilis presents with symptoms requiring imaging of the orbit, face, or neck.
-
C00.0- Malignant neoplasm of external upper lip- MRI may be used to assess tumor extent and involvement in the upper lip region.
-
C00.1- Malignant neoplasm of external lower lip- MRI assists in evaluating malignancy in the lower lip and adjacent tissues.
-
C70.0- Malignant neoplasm of cerebral meninges- Imaging may be required to assess meningeal involvement extending to the orbit, face, or neck.
-
C70.9- Malignant neoplasm of meninges, unspecified- Used when meningeal malignancy is suspected but not specified; MRI helps in localization.
-
C71.0- Malignant neoplasm of cerebrum, except lobes and ventricles- MRI may be used to evaluate tumor spread or involvement in adjacent regions.
-
C71.1- Malignant neoplasm of frontal lobe- Relevant for imaging when frontal lobe tumors may affect orbit, face, or neck.
-
C71.2- Malignant neoplasm of temporal lobe- MRI assists in assessing temporal lobe tumors with possible extension.
-
C71.3- Malignant neoplasm of parietal lobe- Used for imaging parietal lobe tumors impacting nearby structures.
-
C71.4- Malignant neoplasm of occipital lobe- MRI may be indicated for occipital lobe tumors affecting orbit or face.
-
C71.5- Malignant neoplasm of cerebral ventricle- Imaging is relevant for evaluating ventricular tumors with possible extension to orbit, face, or neck.
Related CPT Codes
| CPT Code | Description | Clinical Relationship |
|---|---|---|
70543 | MRI orbit, face, and neck with contrast | Used when only contrast-enhanced imaging is performed. |
70551 | MRI brain without contrast | Used for brain imaging without contrast; may be ordered separately or as an alternative. |
70553 | MRI brain without and with contrast | Used for brain imaging with both non-contrast and contrast sequences; may be used in conjunction or as an alternative. |
70486 | CT orbit, face, and neck with contrast | Alternative imaging modality for similar anatomical regions. |
70491 | CT soft tissue neck with contrast | Alternative or complementary imaging for neck pathology. |
Codes 70543, 70551, and 70553 are commonly used as alternatives or in conjunction with 70544 depending on clinical indications. CT codes 70486 and 70491 may be used when MRI is contraindicated or for additional anatomical detail.
National Reimbursement Benchmarks
National mean rates for CPT code 70544 show a significant gap between Medicare and commercial payers. Medicare's mean rate is $149.13, while the BUCA (average commercial) mean rate is $260.25, highlighting a difference of over $110 per service.
Rate dispersion varies notably across payers. Cigna exhibits the widest spread, with a difference of $214.67 between its 75th and 25th percentiles, indicating substantial variability in contracted rates. In contrast, Aetna has the tightest range at $126.00, suggesting more consistent reimbursement levels. Blue Cross Blue Shield, UnitedHealth Group, and BUCA also show considerable dispersion, while Medicare's range is $152.00.
The table and chart below present the full breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.